- Home
- TPB vs TVTX Comparison
TPB vs TVTX Comparison
Compare TPB & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TPB | TVTX |
|---|---|---|
| Founded | 1988 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Tobacco | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 3.1B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | TPB | TVTX |
|---|---|---|
| Price | $104.68 | $34.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 15 |
| Target Price | ★ $93.75 | $37.21 |
| AVG Volume (30 Days) | 243.2K | ★ 1.4M |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | ★ 0.28% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | $435,716,000.00 | ★ $435,826,000.00 |
| Revenue This Year | $29.47 | $120.36 |
| Revenue Next Year | $10.28 | $37.33 |
| P/E Ratio | $532.68 | ★ N/A |
| Revenue Growth | 51.72 | ★ 114.22 |
| 52 Week Low | $51.48 | $12.91 |
| 52 Week High | $110.55 | $37.50 |
Technical Indicators
Market Signals| Indicator | TPB | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 66.27 | 54.45 |
| Support Level | $96.15 | $33.84 |
| Resistance Level | $106.75 | $35.97 |
| Average True Range (ATR) | 2.84 | 1.42 |
| MACD | 0.38 | -0.36 |
| Stochastic Oscillator | 82.00 | 31.85 |
Price Performance
Historical ComparisonAbout TPB Turning Point Brands Inc.
Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.